Collectively, we demonstrated that preventing REST increase in brain areas involved in ALS disorder extended the survival of SOD1-G93A mice and showed that serum REST may represent a possible prognostic biomarker in ALS patients. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.